Living with a pulmonary arterial hypertension (PAH) diagnosis can be challenging, but there are treatment options available to help manage this condition. One such option is Flolan, a medication that works by dilating blood vessels in the lungs and improving blood flow. In this blog post, we'll explore the benefits of Flolan for patients and caregivers alike. From its mechanism of action to potential side effects, we've got you covered on everything you need to know about Flolan. So let's dive in!
Flolan, also known as epoprostenol sodium, is a medication that helps treat pulmonary arterial hypertension (PAH). This condition causes high blood pressure in the arteries of your lungs and can make it difficult for your heart to pump blood. Flolan works by dilating these constricted arteries, allowing for better blood flow.
The drug is administered through an IV directly into the bloodstream. Patients who use Flolan typically require continuous infusion therapy due to its short half-life. While this may seem daunting, many patients find that the benefits of Flolan outweigh any inconvenience its administration may cause.
Flolan, also known as epoprostenol sodium, is a medication that helps to dilate blood vessels in the lungs. This allows for improved blood flow and oxygenation in patients with pulmonary arterial hypertension (PAH) or related conditions.
One of the key benefits of Flolan is its ability to improve exercise tolerance and reduce symptoms such as shortness of breath and fatigue. Patients may be able to engage in physical activity more easily, improving their quality of life.
Another important benefit is Flolan's ability to prolong survival and improve hemodynamics (blood flow) in PAH patients. Studies have shown that treatment with Flolan can significantly increase 1-year survival rates compared to placebo.
In addition, Flolan may help prevent acute pulmonary hypertensive crises. These episodes can be life-threatening for PAH patients and require emergency medical intervention. By using Flolan regularly, patients may experience fewer crises or less severe episodes when they do occur.
As with any medication, Flolan can cause some side effects in patients. It's important to be aware of these potential side effects prior to starting treatment with Flolan.
One common side effect is pain at the injection site. This can occur due to the continuous infusion pump that delivers Flolan into your bloodstream. The pain may range from mild discomfort to severe pain and may require medical attention if it persists for a prolonged period.
Flolan is a medication that has proven to be a useful treatment for patients suffering from pulmonary arterial hypertension. It works by dilating the blood vessels in the lungs and improving blood flow, which can help reduce symptoms such as shortness of breath and fatigue.
It's important to note that while Flolan has been available for several years, new treatments continue to emerge. Veletri is one such alternative that may offer similar benefits with fewer side effects.
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
healthy despite having advanced cancer.
3.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
4.
PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging
5.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
1.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
2.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
3.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
4.
Blood Donation Sustainability Through Behavioral Science
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation